In this way, we identified the MYC oncoprotein to be significantly inactivated, both in D283 cells following YB-1 knockdown (Z score = −2.1) and in medulloblastoma patients with low YB-1 gene expression (Supplementary Figure S8). The gene discussed is YBX1; the disease is medulloblastoma.